UC2288 induces cell apoptosis of nasopharyngeal carcinoma cells via inhibiting EGFR/ERK pathway

Radiotherapy and chemotherapy are the standard care for patients with nasopharyngeal carcinoma (NPC). These treatments cause some severe toxicity and about 30% of patients develop recurrence and metastases after treatment. UC2288 is structurally similar to sorafenib, a multikinase inhibitor. However...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Renba, Zhu, Xiaodong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797659/
https://www.ncbi.nlm.nih.gov/pubmed/33442398
http://dx.doi.org/10.7150/jca.48282

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797659/
https://www.ncbi.nlm.nih.gov/pubmed/33442398
http://dx.doi.org/10.7150/jca.48282

Ejemplares similares